IGKV1D-8

Across TCGA pan-cancer cohorts, IGKV1D-8 RNA differs between tumor and matched normal tissue in 8 of 18 cancer types tested, making tumor–normal expression one of IGKV1D-8’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where IGKV1D-8 RNA is repressed in tumor relative to normal tissue. In most cancer types IGKV1D-8 is over-expressed in tumor, although a few such as COAD and BRCA show the opposite, repressed pattern.

COAD, LUAD, and KIRC are the cancer types where IGKV1D-8 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in IGKV1D-8 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Female	III,IV	−3.348	<.001	9	view →
LUAD	Female	All	+1.835	<.001	7	view →
KIRC	Male	All	+0.936	<.001	5	view →
BRCA	Female	II,III,IV	−0.712	<.001	4	view →
READ	All	II,III,IV	−1.864	.025	2	view →
LIHC	Male	All	−0.866	<.001	2	view →
KICH	All	All	−0.686	.022	2	view →
STAD	All	IV	−3.850	.035	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 8 strongest of 8 lineages.

IGKV1D-8–COAD

Open the COAD breakdown →